GANX Latest Press Releases

-- October 13, 2026 --

Sibylla Biotech Appoints Usman Azam CEO, Gianluca Fuggetta CFO, and Expands Executive Team to Drive Transition to Clinic Globe Newswire 5:00 AM

-- October 8, 2026 --

Gain Therapeutics to Attend the 2026 Maxim Growth Summit Globe Newswire 7:00 AM

-- October 1, 2026 --

Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration Globe Newswire 9:28 AM

-- September 29, 2026 --

Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson's Disease and Movement Disorders Globe Newswire 5:50 PM

-- September 17, 2026 --

Gain Therapeutics to Participate at ROTH Fifth Annual Healthcare Opportunities Conference Globe Newswire 7:00 AM

-- August 25, 2026 --

Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference Globe Newswire 7:00 AM

-- August 11, 2026 --

Gain Therapeutics Reports Financial Results for Second Quarter 2026 and Provides Corporate Update Globe Newswire 7:00 AM

-- July 16, 2026 --

Gain Therapeutics CEO Gene Mack Issues Letter to Shareholders and Provides Operational Update Globe Newswire 7:00 AM

-- June 29, 2026 --

Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson's Disease Globe Newswire 4:05 PM

-- June 10, 2026 --

Gain Therapeutics to Present at H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit Globe Newswire 7:00 AM

-- May 26, 2026 --

Gain Therapeutics Presents Positive Interim Data from Phase 1b Clinical Study of GT-02287 at 3rd International GBA1 Meeting 2026 Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes